We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
A European review has begun into the safety of radium-223 dichloride following an observed increase in the incidence of deaths and fractures in patients with chemotherapy-naive metastatic castration-resistant prostate cancer receiving radium-223 dichloride in combination with abiraterone acetate (Zytiga) and...
Now only authorised for use in patients with symptomatic bone metastases and no known visceral metastases who have had 2 previous systemic treatments for metastatic castration-resistant prostate cancer or who cannot receive other systemic treatments. Do not use in combination...
Bayer is recalling the listed batches due to reduced potency of the active ingredient
Last month, letters were sent regarding ketoconazole HRA and radium-223 dichloride (Xofigo).
Medicines have been taken out of the regulated medicines’ supply chain during distribution. The products have been parallel imported into the UK by B & S Healthcare from Italy and have been re-labelled in B & S Healthcare livery.
(Merck Serono) Contraindicated for patients with allergies to soya oil - class 4 caution in use. (EL (14)A/15)
A safety review conducted at the end of its routine use during the ongoing human papillomavirus immunisation programme has found that no new risks have been identified for Cervarix, and that the balance of its risks and benefits remains clearly...
A man has been given a 4 month prison sentence at Southwark Crown Court, suspended for 2 years, for the sale and supply of unlicensed erectile dysfunction drugs.
Around 3.5 million unlicensed erection pills worth more than £10 million were seized in the UK in 2019 according to new figures released today by the Medicines and Healthcare products Regulatory Agency (MHRA).
On Friday at Guildford Crown Court Peppino Fiori was subject to a confiscation order under the Proceeds of Crime Act. He must satisfy a confiscation order of £158,159.09.
Investigation by the Medicines and Healthcare products Regulatory Agency (MHRA) results in guilty pleas for supplying unlicensed, and potentially dangerous, medicinal products.
Decisions made by MHRA following investigations into complaints about advertising for licensed medicines.
Two brothers were today sentenced at Chelmsford Crown Court for the illegal importation and sale of unlicensed erectile dysfunction drugs.
A Kenley man has been sentenced for the supply and possession of unlicensed medicines.
A Liverpool man has been jailed for the illegal importation and sale of unlicensed medicines.
Upper Tribunal Tax and Chancery decision of Mr Justice Henderson and Judge Sinfield on 19 July 2016.
Employment Tribunal decision.
A massive haul of fake and unlicensed Viagra, worth around £13 million, was seized by UK Border Agency officers during 2010..
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).